knowledge -WSS

knowledge

author：leisure time 2025-08-26 23:48:11 - browse：67

a man holds his vaccination reminder card and a "CVS Health" sticky note. -- health business coverage from STAT — Wilfredo Lee/AP

Medicare Advantage members continue to go to the doctor and get health care procedures a lot more than predicted, CVS Health executives said at the J.P. Morgan Healthcare Conference on Monday.

A persistent theme for health insurance companies throughout 2023 has been their Medicare Advantage members using more care than their actuaries projected, which has been eating into the profits they get from federally funded health care premiums.

CVS, a major seller of Medicare Advantage plans, has not yet closed the books on its 2023 finances. But CVS’ new CFO, Tom Cowhey, disclosed on Monday that costs for its Medicare Advantage members now “might exceed” their already-elevated guidance from November as the company sifts through fourth-quarter data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： What to expect as Trump is arraigned on his Jan 6. indictment

WSS

No plane should take off without an EpiPen onboard

What the US credit downgrade means for the economy, your finances

CRISPR pioneers react to Casgevy, first gene

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Readout LOUD podcast: A CRISPR milestone, biotech mixology

New safety details link Apellis eye drug to rare cases of blindness

entertainment

knowledge

hotspot

Medicare details structure of new drug price negotiation program

Gain of function research would be limited under House proposal

Sports medicine is finally prioritizing gender equality

Mega Millions pot grows to $1.25 billion after no winner

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Surge of respiratory disease in China has likely explanation

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Sage hopes for a blockbuster in antidepressant now before FDA

In age of alternative facts, a scholarly course on calling out crap

‘Oppenheimer’ and the risks of AI in health care

knowledge

Micronoma's microbiome cancer diagnostic approach under fire

Breakthrough Alzheimer’s drugs are inaccessible in rural states

NYU radiologists take on the challenge of expensive MRI machines

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

CRISPR pioneers react to Casgevy, first gene

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Wikipedia

explore

explore

leisure time